Codman Certas
Device Neuro Critical Care
PDI 10381780529033
General payments
$667,320
Research payments
$17,300
Through program year 2025, $667,320 in general payments and $17,300 in research payments were reported against Codman Certas (Neuro Critical Care).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $223,543 | 1,356 |
| 2024 | General | $172,171 | 1,199 |
| 2023 | General | $127,812 | 1,067 |
| 2023 | Research | $17,300 | 4 |
| 2022 | General | $88,804 | 1,155 |
| 2021 | General | $54,989 | 1,124 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 70 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 43 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,901 general · 4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.